Etiology and outcome of liver granulomatosis: A retrospective study of 21 cases;Étiologies et évolution des hépatites granulomateuses: Étude rétrospective de 21 cas consécutifs

Revue de Medecine Interne

Volumn 31, Issue 2, 2010, Pages 97-106

  Martin Blondel, G ^a   Camara, B ^a   Selves, J ^a   Robic, M A ^a   Thebault, S ^a   Bonnet, D ^a   Alric, L ^a  

^a CHU PURPAN   (France)

Author keywords

Common variable immunodeficiency; Liver; Liver granulomatosis; Portal hypertension; Sarcoidosis

Indexed keywords

ADULT; AGED; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYPTOCOCCOSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; LIVER ADENOMA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER GRANULOMA; MALE; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; SARCOIDOSIS; SCHISTOSOMIASIS; SJOEGREN SYNDROME; SYSTEMIC DISEASE; TUBERCULOSIS; BILIARY CIRRHOSIS; ERDHEIM CHESTER DISEASE; LIVER DISEASE; PATHOLOGY; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS;

ADULT; BEHCET SYNDROME; CHOLANGITIS, SCLEROSING; CRYPTOCOCCOSIS; ERDHEIM-CHESTER DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; RETROSPECTIVE STUDIES; SARCOIDOSIS; SJOGREN'S SYNDROME;

EID: 75549086501     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.10.430     Document Type: Article

References (33)

1. Wainwright H. Hepatic granulomas. Eur J Gastroenterol Hepatol 2007, 19:93-95.
2. Matheus T., Munoz S. Granulomatous liver disease and cholestasis. Clin Liver Dis 2004, 8:229-246.
3. Dourakis S.P., Saramadou R., Alexopoulou A., Kafiri G., Deutsch M., Koskinas J., et al. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol 2007, 19:101-104.
4. Drebber U., Kasper H.U., Ratering J., Wedemeyer I., Schirmacher P., Dienes H.P., et al. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis-a study of 442 cases. Liver Int 2008, 28:828-834.
5. Gaya D.R., Thorburn D., Oien K.A., Morris A.J., Stanley A.J. Hepatic granulomas: a 10-year single-centre experience. J Clin Pathol 2003, 56:850-853.
6. Mert A., Ozaras R., Bilir M., Tahan V., Cetinkaya A., Yirmibescik S., et al. The etiology of hepatic granulomas. J Clin Gastroenterol 2001, 32:275-276.
7. Sanai F.M., Ashraf S., Abdo A.A., Satti M.B., Batwa F., Al-Husseini H., et al. Hepatic granuloma: decreasing trend in a high-incidence area. Liver Int 2008, 28:1402-1407.
8. Valla D.C. Granulomatoses hépatiques. Rev Med Interne 2005, 26(Suppl. 1):S7-S8.
9. Gousseff M., Mechai F., Lecuit M., Lortholary O. Les granulomatoses systémiques d'origine infectieuse. Rev Med Interne 2008, 29:15-27.
10. Pavic M., Debourdeau P., Vacelet V., Rousset H. Place de la pathologie granulomateuse au cours des cancers. Rev Med Interne 2008, 29:39-45.
11. Ayyala U.S., Padilla M.L. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol 2006, 9:475-483.
12. Ozaras R., Tahan V., Mert A., Uraz S., Kanat M., Tabak F., et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol 2004, 38:449-452.
13. Ludwig J., Colina F., Poterucha J.J. Granulomas in primary sclerosing cholangitis. Liver 1995, 15:307-312.
14. Shorbagi A., Bayraktar Y. Primary sclerosing cholangitis - what is the difference between east and west?. World J Gastroenterol 2008, 14:3974-3981.
15. Muratori P., Muratori L., Guidi M., Maccariello S., Pappas G., Ferrari R., et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003, 132:473-476.
16. Fasano M.B., Sullivan K.E., Sarpong S.B., Wood R.A., Jones S.M., Johns C.J., et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 1996, 75:251-261.
17. Mechanic L.J., Dikman S., Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997, 127:613-617.
18. Le Bail B., Jouhanole H., Deugnier Y., Salame G., Pellegrin J.L., Saric J., et al. Liver adenomatosis with granulomas in two patients on long-term oral contraceptives. Am J Surg Pathol 1992, 16:982-987.
19. Miller E.B., Shichmanter R., Friedman J.A., Sokolowski N. Granulomatous hepatitis and Sjögren's syndrome: an association. Semin Arthritis Rheum 2006, 36:153-158.
20. Montano-Loza A.J., Crispin-Acuna J.C., Remes-Troche J.M., Uribe M. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjögren's syndrome. Ann Hepatol 2007, 6:150-155.
21. Bayraktar Y., Ozaslan E., Van Thiel D.H. Gastrointestinal manifestations of Behçet's disease. J Clin Gastroenterol 2000, 30:144-154.
22. Devaney K., Goodman Z.D., Epstein M.S., Zimmerman H.J., Ishak K.G. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. Am J Surg Pathol 1993, 17:1272-1280.
23. Valla D., Pessegueiro-Miranda H., Degott C., Lebrec D., Rueff B., Benhamou J.P. Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med 1987, 63:531-544.
24. Ebert E.C., Kierson M., Hagspiel K.D. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 2008, 103:3184-3192.
25. Moreno-Merlo F., Wanless I.R., Shimamatsu K., Sherman M., Greig P., Chiasson D. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology 1997, 26:554-560.
26. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34-48.
27. Ward C., Lucas M., Piris J., Collier J., Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008, 153:331-337.
28. Malamut G., Ziol M., Suarez F., Beaugrand M., Viallard J.F., Lascaux A.S., et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008, 48:74-82.
29. Wanless I.R. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990, 11:787-797.
30. Paumgartner G., Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 2004, 8:67-81.
31. Kennedy P.T., Zakaria N., Modawi S.B., Papadopoulou A.M., Murray-Lyon I., du Bois R.M., et al. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol 2006, 18:721-726.
32. Malphettes M., Oksenhendler E., Galicier L., Fieschi C. Maladie granulomateuse au cours du déficit immunitaire commun variable. Rev Med Interne 2008, 29:28-32.
33. Thatayatikom A., Thatayatikom S., White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005, 95:293-300.